Bharat Parenterals’ arm clears USFDA inspection at manufacturing facility in Vadodara

05 May 2025 Evaluate

Bharat Parenterals’ subsidiary -- Innoxel Lifesciences has successfully cleared United States Food and Drug Administration (USFDA) inspection at its manufacturing facility in Vadodara, Gujarat.

The inspection was conducted from April 28, 2025 to May 2, 2025 and concluded with the issuance of a single minor observation under Form 483.

This outcome reflects Innoxel Lifesciences’ ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence across its manufacturing operations. The successful completion of this inspection further strengthens the company’s position in regulated markets and enhances its readiness to serve global customers with high-quality pharmaceutical products.

Bharat Parenterals is engaged in to the business of the Pharmaceuticals & Drugs. 


Bharat Parenterals Share Price

1100.00 39.00 (3.68%)
12-Dec-2025 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.60
Dr. Reddys Lab 1270.50
Cipla 1515.50
Zydus Lifesciences 928.20
Lupin 2095.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×